CDXC’s latest rating updates from top analysts.

ChromaDex Corporation’s recently made public that its Director Jaksch Frank L Jr acquired Company’s shares for reported $11830.0 on Jun 12. In the deal valued at $1.69 per share,7,000 shares were bought. As a result of this transaction, Jaksch Frank L Jr now holds 231,339 shares worth roughly $ 0.36 million.

Then, Fried Robert N bought 7,000 shares, generating $9,940 in total proceeds. Upon buying the shares at $1.42, the Chief Executive Officer now owns 95,001 shares.

Before that, Rubin Steven D bought 7,000 shares. ChromaDex Corporation shares valued at $10,220 were divested by the Director at a price of $1.46 per share. As a result of the transaction, Rubin Steven D now holds 7,000 shares, worth roughly $10920.0.

Oppenheimer downgraded its ChromaDex Corporation [CDXC] rating to a Perform from a an Outperform in a research note published on Friday.

Price Performance Review of CDXC

On Friday, ChromaDex Corporation [NASDAQ:CDXC] saw its stock fall -1.89% to $1.56. On the same session, the stock had its day’s lowest price of $1.56, but rose to a high of $1.60. Over the last five days, the stock has gained 4.00%. ChromaDex Corporation shares have fallen nearly -7.14% since the year began. Nevertheless, the stocks have risen 8.33% over the past one year. While a 52-week high of $2.24 was reached on 01/17/23, a 52-week low of $1.15 was recorded on 04/28/23. SMA at 50 days reached $1.6084, while 200 days put it at $1.6293. A total of 52117.0 shares were traded, compared to the trading of 39900.0 shares in the previous session.

Levels Of Support And Resistance For CDXC Stock

The 24-hour chart illustrates a support level at 1.5467, which if violated will result in even more drops to 1.5333. On the upside, there is a resistance level at 1.5867. A further resistance level may holdings at 1.6133. The Relative Strength Index (RSI) on the 14-day chart is 48.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0381, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 26.67%. Stochastics %K at 82.64% indicates the stock is a selling.

How much short interest is there in ChromaDex Corporation?

A steep rise in short interest was recorded in ChromaDex Corporation stocks on Aug 14, 2023, dropping by -0.14 million shares to a total of 1.39 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.53 million shares. There was a decline of -10.07%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.52% of the overall stock float, the days-to-cover ratio (short ratio) fell to 19.47.

ChromaDex Corporation [CDXC] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 3,024,723 shares, or roughly 4.04% of the outstanding CDXC shares. In other words, the investor’s shares have fallen by -84,376 from its previous 13-F filing of 3109099.0. Additionally, Tieton Capital Management LLC increased 0.84% of its stake after which the total value it holdings stand at $4,420,655. Over the last quarter, BlackRock Fund Advisors purchased 11,299 shares of ChromaDex Corporation, while Geode Capital Management LLC bought -33,036 shares. At present, Renaissance Technologies LLC is holding 460,539 shares valued at $0.79 million. GMT Capital Corp. owned 296,905 shares of the company at the time of its most recent 13F filing, worth $0.51 million.

According to FactSet, ChromaDex Corporation’s share price will average $5.17 in the next year, based on opinions of analysts polled by the firm. This is up nearly 214.47 percent from its previous closing price of $1.59. Analysts expect ChromaDex Corporation stock to reach the higher price of $8.00, while the lowest price estimate is $2.00. However, 5 analysts have rated CDXC stock as a Buy in their predictions for 2023.